Pneumococcal Pure Polysaccharide Vaccination in Pediatric Patients With Chronic Heart Disease

Insights

Pneumococcal polysaccharide vaccine-23 (PPSV23) use was low in children with chronic heart disease (CHD). Many missed vaccination opportunities suggest improved strategies are needed for this high-risk group.

Area of Science:

  • Pediatric Cardiology
  • Vaccinology
  • Public Health

Background:

  • Children with chronic heart disease (CHD) are at increased risk for pneumococcal infections.
  • Pneumococcal polysaccharide vaccine-23 (PPSV23) is recommended for certain high-risk pediatric populations.
  • Vaccination rates and missed opportunities for PPSV23 in pediatric CHD patients are not well-characterized.

Purpose of the Study:

  • To describe the utilization of pneumococcal polysaccharide vaccine-23 (PPSV23) in pediatric patients diagnosed with chronic heart disease (CHD).
  • To identify missed opportunities for PPSV23 vaccination in this high-risk cohort.

Main Methods:

  • A single-center retrospective cohort study was conducted.
  • Included patients were aged 2-18 years with a diagnosis of CHD.
  • Data collected included PPSV23 vaccination status, clinic visit frequency, and incidence of pneumonia.

Main Results:

  • 392 pediatric patients with CHD were included; mean age was 8.8 years.
  • Only 10.2% (40 patients) had documented PPSV23 vaccination.
  • Patients had a median of three clinic visits in 2019, indicating potential missed opportunities.

Conclusions:

  • PPSV23 vaccination rates are low among pediatric patients with CHD.
  • Numerous missed opportunities for vaccination were documented.
  • The lack of routine inclusion of PPSV23 in pediatric schedules may contribute to low uptake.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
247
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14